Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Non-Current Debt: 2016-2018

Historic Non-Current Debt for Anaptysbio (ANAB) over the last 2 years, with Dec 2018 value amounting to $625,000.

  • Anaptysbio's Non-Current Debt fell 91.73% to $625,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $625,000, marking a year-over-year decrease of 91.73%. This contributed to the annual value of $625,000 for FY2018, which is 91.73% down from last year.
  • Latest data reveals that Anaptysbio reported Non-Current Debt of $625,000 as of Q4 2018, which was down 74.06% from $2.4 million recorded in Q3 2018.
  • Over the past 5 years, Anaptysbio's Non-Current Debt peaked at $13.8 million during Q4 2016, and registered a low of $625,000 during Q4 2018.
  • Its 3-year average for Non-Current Debt is $7.5 million, with a median of $7.6 million in 2017.
  • Data for Anaptysbio's Non-Current Debt shows a maximum YoY crashed of 91.73% (in 2018) over the last 5 years.
  • Anaptysbio's Non-Current Debt (Quarterly) stood at $13.8 million in 2016, then tumbled by 45.30% to $7.6 million in 2017, then crashed by 91.73% to $625,000 in 2018.
  • Its last three reported values are $625,000 in Q4 2018, $2.4 million for Q3 2018, and $4.1 million during Q2 2018.